Pall expands again in chromatography
Filtration and separation company Pall has made another acquisition in the chromatography sector with the purchase of Euroflow (UK) for an undisclosed amount.
Archives for January 26, 2005
New active agents against leishmaniasis
Scientists have targeted the alkaloids of the quinolines chemical family, which have proved effective against visceral leishmaniasis treating this severe form of the disease with its antiparasitic properties.
Mergen launches OEM business for DNA microarrays
Biotechnology company Mergen Limited has announced the launch of a new service reselling DNA microarrays for gene expression analysis. The service signals a cost effective approach to providing custom-built microarrays to the market.
Dow spins out dendrimer portfolio to nanotech firm
Dow Chemical has signed over its entire portfolio of intellectual property and technology in the area of dendrimers - branched polymers with applications in targetted drug delivery - to US firm Dendritic NanoTechnologies and Starpharma of Australia.
Procognia and Hamilton enter array deal
Procognia and Hamilton life sciences have entered into a joint collaboration, which focuses on the automated growth and handling of Procognia's functional human protein arrays.
UK National Biomanufacturing Centre on track for '06 start-up
Construction of the UK National Biomanufacturing Centre, an ambitious project aimed at helping biotechnology start-ups get their product ideas into clinical trials, is progressing on schedule and should be ready to start production at the beginning...
Quantum dot market to exceed €384 million by 2009
The total global market for Quantum Dots (QD) is expected to exceed $0.5 billion (€384 million) despite its expense and the novelty of this technology. The core of this industry drive is expected to play out in the life sciences and biomedical arena.
Upstate introduces drug efficacy service
Serologicals company, Upstate Group, has introduced a one-of-a-kind service, which aims to provide drug development companies with valuable insights into therapies and efficacy within cells.
Transgenic specialist Pharming raises €7m
Pharming of the Netherlands, which is pioneering the use of transgenic animals for the production of biologics, has raised €7 million in new funding and will use the proceeds to advance its portfolio of clinical drug candidates.